Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

41,824 stories, page 487 of 698

Advanced search

🌍Jul 18Researchdoi.orgTier 1 · Research record

A multidatabase bibliometric analysis of phytochemical metabolomics research in Africa and its implications for equitable drug discovery

CrossrefOriginal source

🌍Jul 18Researchdoi.orgTier 1 · Research record

Impact of a Moderate Caloric Deficit and Aerobic Exercise On Body Composition in Obese Patients: A Large Single-arm Quasi-experimental Study Using Bioelectrical Impedance Analysis

CrossrefOriginal source

🌍Jul 18Researchdoi.orgTier 1 · Research record

Protein tyrosine kinase inhibitors

CrossrefOriginal source

🌍Jul 18Researchdoi.orgTier 1 · Research record

Entrectinib/Rivaroxaban

CrossrefOriginal source

🌍Jul 18Researchdoi.orgTier 1 · Research record

Cocaine

CrossrefOriginal source

🌍Jul 18Researchdoi.orgTier 1 · Research record

Carbamazepine

CrossrefOriginal source

🌍Jul 18Researchdoi.orgTier 1 · Research record

Global Viral Lower Respiratory Disease Episodes, Hospitalisations, and Clinical Outcomes by Aetiology, 2010–2021

CrossrefOriginal source

🌍Jul 18Researchdoi.orgTier 1 · Research record

Identifying adverse drug events in children with congenital heart disease using machine learning techniques and multi-domain descriptors

CrossrefOriginal source

🌍Jul 18Researchdoi.orgTier 1 · Research record

Treatable Traits in Bronchiectasis: A Precision Medicine Framework Aligned with the 2025 ERS Clinical Practice Guidelines

CrossrefOriginal source

🌍Jul 18Researchdoi.orgTier 1 · Research record

Effects of plyometric-based high-intensity interval training on muscle-to-fat ratio in children: protocol for a randomized controlled trial in primary school settings

CrossrefOriginal source

🌍Jul 18Researchdoi.orgTier 1 · Research record

Efficacy and Safety of Statins in Patients with Liver Cirrhosis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials with Trial Sequential Analysis

CrossrefOriginal source

🌍Jul 18Researchdoi.orgTier 1 · Research record

Expert Consensus on the Clinical Application of Sulodexide in Vascular Diseases

CrossrefOriginal source

🌍Jul 18Researchdoi.orgTier 1 · Research record

Integrative analysis identifies candidate biomarkers for bladder cancer: evidence from genomic and clinical validation

CrossrefOriginal source

🌍Jul 18Researchdoi.orgTier 1 · Research record

Fear of Nighttime Hypoglycemia: Perspectives of Diabetes Providers and Caregivers

CrossrefOriginal source

🌍Jul 18Researchdoi.orgTier 1 · Research record

IgG4-Related Hepatic Disease Unmasking Hepatic Actinomycosis

CrossrefOriginal source

🌍Jul 18Researchdoi.orgTier 1 · Research record

Evaluation of the clinical efficacy of accelerated photoactivated chromophore for keratitis-CXL for early to mid-stage fungal keratitis: a prospective, multicenter randomized controlled trial

CrossrefOriginal source

🌍Jul 18Researchdoi.orgTier 1 · Research record

Clinical Utility and Diagnostic Yield of Duodenal Versus Jejunal Aspirates for Small Intestinal Bacterial or Fungal Overgrowth

CrossrefOriginal source

🌍Jul 18Researchdoi.orgTier 1 · Research record

Feasibility, Acceptability, and Preliminary Effects of a Nurse-Delivered Self-Management Program for Individuals with Inflammatory Bowel Disease: A Pilot Randomized Controlled Trial

CrossrefOriginal source

🌍Jul 18Researchdoi.orgTier 1 · Research record

Adverse Childhood Experiences and Sexual Risk Behaviours: Associations with Offline and Online Sexual Activity Among Canadian Youth

CrossrefOriginal source

🌍Jul 18Researchdoi.orgTier 1 · Research record

Implementation of State Prescription Drug Monitoring Program Mandatory Checking Requirements and Prescribed Opioid Analgesic Use Among Women With and Without HIV in The Women’s Interagency HIV Study: A Longitudinal Observational Study Using Staggered Adoption Difference-in-differences Analyses

CrossrefOriginal source

🌍Jul 18Researchdoi.orgTier 1 · Research record

Risk of second primary malignancies after bladder cancer diagnosed at a young age: a SEER population-based analysis

CrossrefOriginal source

🌍Jul 18Researchdoi.orgTier 1 · Research record

Stereotactic radiosurgery for treatment-refractory obsessive-compulsive disorder: a systematic review of targets, targeting methods, lesion geometry, and clinical outcomes

CrossrefOriginal source

🌍Jul 18Researchdoi.orgTier 1 · Research record

Cefepime susceptibility testing in AmpC-hyperproducing Enterobacter cloacae complex: limitations of routine methods and a pragmatic diagnostic approach

CrossrefOriginal source

🌍Jul 18Researchdoi.orgTier 1 · Research record

A conceptual regeneration–maintenance decision aid for class II furcation involvement

CrossrefOriginal source

🌍Jul 18Researchdoi.orgTier 1 · Research record

The influence of urban versus rural residence and travel distance on net income, out-of-pocket payments and quality of life in German head and neck cancer survivors

CrossrefOriginal source

🌍Jul 18Researchdoi.orgTier 1 · Research record

Letter to the editor regarding “Impact of gross tumor morphology on the clinical outcomes of colon cancer: multicenter retrospective cohort study”

CrossrefOriginal source

🌍Jul 18Researchdoi.orgTier 1 · Research record

Favorable clinical outcomes of biologic and targeted therapies in refractory eosinophilic fasciitis: a case-based systematic review

CrossrefOriginal source

🌍Jul 18Researchdoi.orgTier 1 · Research record

Predicting postoperative coronal imbalance in Lenke 1/2 adolescent idiopathic scoliosis: A machine learning model with clinical interpretability

CrossrefOriginal source

🌍Jul 18Researchdoi.orgTier 1 · Research record

Vancomycert: A Certified Neuro-Symbolic Drug Delivery System (Case Study)

CrossrefOriginal source

🌍Jul 18Researchdoi.orgTier 1 · Research record

Progress report on new epilepsy treatments: A summary of the Eighteenth Eilat Conference on New Antiepileptic Drugs and Devices ( <scp>EILAT XVIII</scp> ). <scp>II</scp> . Treatments in more advanced clinical development

CrossrefOriginal source

🌍Jul 18Researchdoi.orgTier 1 · Research record

Asymmetric Zn─N <sub>3</sub> O <sub>1</sub> Single‐Atom Sites Promote Hydroxyl Radical Generation for Natural‐Light‐Driven Inactivation of Drug‐Resistant Bacteria

CrossrefOriginal source

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

DIMERIX EXPANDS PIPELINE WITH ACQUISITION OF PHASE 2 READY ASSET FOR ACUTE KIDNEY INJURY

Macau BusinessOriginal source

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

Milind Deora backs Maha FDA crackdown, pitches public dashboard for hygiene compliance

Social News XYZOriginal source

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

Telix Completes Patient Enrollment in TLX591-Px (Illuccix®) Japan Phase 3 Study

Macau BusinessOriginal source

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

Multi-omics integration for drug target discovery: What the data actually shows

Drug Discovery NewsOriginal source

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

New cholesterol pill Lipfendra gets FDA approval: 2 experts weigh in

AOL.comOriginal source

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

How FDA Review of VOXZOGO Full-Approval Data at BioMarin (BMRN) Has Changed Its Investment Story

simplywall.stOriginal source

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

Bombay HC Directs Fresh FDA Inspection Of Park Inn By Radisson Navi Mumbai, Sets Aside FSSAI Licence

Free Press JournalOriginal source

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

FAMU Appoints Vanessa B. Sheppard as Dean of the College of Pharmacy and Pharmaceutical Sciences/ Institute of Public Health

Florida A&M University - FAMUOriginal source

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

New cholesterol drug receives FDA approval

McKnight's Long-Term Care NewsOriginal source

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

This Week at FDA: FDA staff raise concerns about peptide conflicts, top Democrat wants DOGE investigation, and more

RAPSOriginal source

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

Recall roundup: Dozens of popular everyday items have been recalled nationwide

WXIIOriginal source

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

FDA Inspects MANIT Hostels After Students Fall Ill, Finds Alleged Hygiene Lapses

Free Press JournalOriginal source

🇺🇸Jul 18Researchatlasventure.comTier 2 · Direct publisher

The Plus-1 in “The Room Where It Happens”: A Survival Guide for Board Observers

Atlas VentureOriginal source

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

Industry wants more clarity on NGS for assessing gene therapy safety

RAPSOriginal source

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

Krystal Biotech Rises as Investors Lean on Commercial Momentum and Pipeline Catalysts

Quiver QuantitativeOriginal source

🌍Jul 18Researchindicalab.comTier 2 · Direct publisher

New! ADC Target Scoring Module

Indica LabsOriginal source

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

This Biotech Position Gave Us Gains In A Choppy Market

Investor's Business DailyOriginal source

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

Erasca: A Credible Rival To Revolution's Daroxonrasib, At A Cheaper Price Point (ERAS)

Seeking AlphaOriginal source

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

John Maraganore Says Lilly’s Trillion-Dollar Bet Is a Race Against Its Own Obesity Franchise

finance.biggo.comOriginal source

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

West Pharmaceutical Services Inc. stock underperforms Friday when compared to competitors

MarketWatchOriginal source

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

NKGen Biotech (NKGN) alters collateral on $5M credit facility

Stock TitanOriginal source

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

PharmaCyte Biotech (PMCB) cancels erroneous stock option grant

Stock TitanOriginal source

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

PharmaCyte Biotech (PMCB) amends Form 4 to cancel option grant

Stock TitanOriginal source

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

PharmaCyte Biotech (PMCB) director corrects erroneous, cancelled option grant

Stock TitanOriginal source

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

"Give time to comply": Shiv Sena's Sanjay Nirupam on FDA's milk packaging norms

indiagazette.comOriginal source

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

Health Headlines: Challenges, Outbreaks, and Innovations

DevdiscourseOriginal source

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

Thousands of Bottles of Prescription Antihistamine Recalled, FDA Notice Says

NTD NewsOriginal source

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

Experts: Ending adequate provision would shut down prescription drug ads

RAPSOriginal source

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

Novo Nordisk to launch lower-cost Ozempic copy in South Africa

ReutersOriginal source